GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

Contributed by: Business Wire

Logo

Images

T cells helping immune system to fight cancer cells in response to immunotherapies (Photo: Business Wire)

Business Wire embedded0

Tags

Technology

Clinical Trials

Health Technology

Software

Biotechnology

Health

Pharmaceutical

Artificial Intelligence

Oncology

Society for Immunotherapy of Cancer

More Like This

Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy

NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

UK-backed AI companies to transform British cancer care and spark new drug breakthroughs

Elsevier

The ‘Insights 2024: Attitudes toward AI’ Report Reveals Researchers and Clinicians Believe in AI's Potential but Demand Transparency in Order to Trust Tools

PR Newswire associated0

Optellum showcases AI for precision lung cancer treatment at ASCO 2024

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

1 in 2 UK Doctors Report They Will Not Use AI to Treat Patients